Journal of Allergy and Clinical Immunology Archive — Page 1 of 1

A slice of toast spread with peanut butter sits beside a spoon holding a small amount of peanut butter; a crossed-out peanut symbol on the toast indicates avoiding peanuts.
June 3, 2022

Food allergy linked to lower risk of SARS-CoV-2 infection

By Nancy Humphrey
Contributors to the COVID-19 microbiome study include (front row, from left) Julie Bastarache, MD, Meghan Shilts, MS, MHS, (middle row, from left) Jodell Jackson, PhD, Suman Das, PhD, Angela Jones, MS, (back row, from left) Jonathan Schmitz, PhD, MD, Simon Mallal, MBBS, and Jordan Best, PhD.
March 11, 2021

‘Friendly’ bacteria may impact COVID severity

The U.S. Centers for Disease Control and Prevention (CDC) has awarded Vanderbilt University Medical Center a two-year, $3.7-million contract to determine genetic and bacterial factors that may increase the risk for severe illness and death from COVID-19.

By Bill Snyder
Two researchers in white lab coats stand in a laboratory beside workbench equipment and sample containers.
February 28, 2019

Gene identified that increases risk of antibiotic reaction

Researchers at Vanderbilt University Medical Center and colleagues have identified a gene that increases the risk for a severe and potentially life-threatening reaction to the commonly prescribed antibiotic vancomycin.

By Bill Snyder
January 17, 2019

Study finds unique form of chronic sinusitis in older patients

Older patients with a diagnosis of chronic sinusitis — a disease of the nasal cavity and paranasal sinuses that often persists over many years — have a unique inflammatory signature that may render them less responsive to steroid treatment, according to a new study published by Vanderbilt researchers.

By Kelsey Herbers
Glowing white DNA double helix over a blue background with circuit-board patterns and light effects.
August 2, 2018

Connecting an asthma gene to leukemia

A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered.

By Leigh MacMillan
Five researchers pose in a laboratory beside a microscope and shelves of scientific supplies. From left: Kevin Niswender, R. Stokes Peebles, Tina Hartert, Lisa Bastarache, and Melissa Bloodworth.
July 12, 2018

Team explores diabetes drug’s ability to treat RSV infection

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.

By Leigh MacMillan